drugset / Trial / NCT00002385

The Safety and Effectiveness of Fozivudine Tidoxil in HIV-1 Infected Patients

NCT00002385 ↗

Double-blindTreatment

Summary

To identify doses of fozivudine tidoxil that are well tolerated and produce measurable antiviral activity. To identify the adverse event profile that defines the maximum tolerated dose. To characterize the single- and multiple-dose pharmacokinetics of fozivudine and its metabolites. To correlate the adverse event profile and antiviral activity of fozivudine with pharmacokinetic parameters.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Fozivudine tidoxil Small molecule — —